Self-Care for Lymphedema in Patients With Breast Cancer
NCT ID: NCT00670644
Last Updated: 2017-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
51 participants
OBSERVATIONAL
2006-05-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Promoting Adherence to Lymphedema Self-care
NCT01779063
Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema
NCT00679185
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
NCT06144164
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
NCT05056207
Efficacy of Home-based Treatment for Breast Cancer-related Lymphedema
NCT06783543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* To systematically identify and describe the barriers to completing recommended at home self-care of lymphedema in patients with breast cancer.
* To identify patient recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others.
* To identify the current at home self-care practices of breast cancer survivors with treatment treated lymphedema.
Secondary
* To examine the relationship between at home self-care activities and symptoms in breast cancer survivors with lymphedema.
* To examine the relationship between at home self-care activities and quality of life in breast cancer survivors with lymphedema.
* To identify patient-perceived benefits to at home self-care.
OUTLINE: Patients complete questionnaires about their breast cancer diagnosis and treatment history, lymphedema history and problems, and years of education and income. Patients also complete surveys about home self-care practices for lymphedema and any benefits, burdens, or barriers of at home care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire administration
Completed self-report form
survey administration
Completed self-report form-other
quality-of-life assessment
Completed self-report form qol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
PATIENT CHARACTERISTICS:
* Menopausal status not specified
* English speaking
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
18 Years
120 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheila Ridner
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shiela H. Ridner, MSN, PhD, RN
Role: STUDY_CHAIR
Vanderbilt-Ingram Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VU-VICC-SUPP-0628
Identifier Type: -
Identifier Source: secondary_id
VU-VICC-060480
Identifier Type: -
Identifier Source: secondary_id
CDR0000587714
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.